• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀可提高接受高胆固醇血症治疗患者的血清骨钙素浓度。

Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia.

作者信息

Chan M H, Mak T W, Chiu R W, Chow C C, Chan I H, Lam C W

机构信息

Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong.

出版信息

J Clin Endocrinol Metab. 2001 Sep;86(9):4556-9. doi: 10.1210/jcem.86.9.8001.

DOI:10.1210/jcem.86.9.8001
PMID:11549708
Abstract

Animal studies, experimental models on cell lines, and epidemiological case-control studies have all suggested the possibility that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors have a beneficial effect on bone metabolism. However, all epidemiological studies are not prospective in nature and based on either measurement of bone mineral density or fracture risk. They also differ in recruitment criteria, definition of statin exposure, and outcome assessment. We performed a first prospective study using specific biochemical bone markers on 17 hypercholesterolaemic non-osteoporotic subjects treated with a therapeutic dose of simvastatin 20 mg daily for 4 weeks. Our results show that serum osteocalcin concentration increased significantly (p-value < 0.05) 4 weeks after therapy, whereas other bone markers including serum bone-specific alkaline phosphatase activity, urine deoxypyridinoline, and urine cross-linked N-telopeptides of type I collagen did not show any significant changes. Our data support that simvastatin causes a beneficial effect on bone metabolism as reflected by an increase in serum osteocalcin concentration. This added beneficial effect of statins on bone metabolism could potentially allow statins to become the first effective anabolic agent for the treatment of osteoporosis. We urge that priority should be given to a randomised controlled study to re-evaluate this group of drugs.

摘要

动物研究、细胞系实验模型以及流行病学病例对照研究均表明,3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂可能对骨代谢具有有益作用。然而,所有流行病学研究本质上并非前瞻性研究,且并非基于骨密度测量或骨折风险评估。它们在招募标准、他汀类药物暴露的定义以及结局评估方面也存在差异。我们对17名高胆固醇血症非骨质疏松患者进行了一项前瞻性研究,这些患者每日接受20毫克辛伐他汀治疗剂量治疗4周,并使用特定的生化骨标志物进行检测。我们的结果显示,治疗4周后血清骨钙素浓度显著升高(p值<0.05),而其他骨标志物,包括血清骨特异性碱性磷酸酶活性、尿脱氧吡啶啉和尿I型胶原交联N-端肽均未显示任何显著变化。我们的数据支持辛伐他汀对骨代谢具有有益作用,这一点通过血清骨钙素浓度的升高得以体现。他汀类药物对骨代谢的这种额外有益作用可能会使他汀类药物成为治疗骨质疏松症的首个有效合成代谢药物。我们敦促应优先进行一项随机对照研究,以重新评估这组药物。

相似文献

1
Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia.辛伐他汀可提高接受高胆固醇血症治疗患者的血清骨钙素浓度。
J Clin Endocrinol Metab. 2001 Sep;86(9):4556-9. doi: 10.1210/jcem.86.9.8001.
2
Effects of statins on biomarkers of bone metabolism: a randomised trial.他汀类药物对骨代谢生物标志物的影响:一项随机试验。
Nutr Metab Cardiovasc Dis. 2001 Apr;11(2):84-7.
3
Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.辛伐他汀对绝经后骨质减少患者骨密度和重塑参数的影响:1年随访研究
Clin Rheumatol. 2005 Sep;24(5):447-52. doi: 10.1007/s10067-004-1053-x. Epub 2005 Mar 2.
4
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.辛伐他汀对骨转换和骨密度的影响:一项针对绝经后骨质减少女性的1年随机对照试验。
J Bone Miner Res. 2004 May;19(5):737-44. doi: 10.1359/JBMR.040209. Epub 2004 Feb 16.
5
Short-term reduction in bone markers with high-dose simvastatin.高剂量辛伐他汀使骨标志物短期内减少。
Osteoporos Int. 2005 Oct;16(10):1272-6. doi: 10.1007/s00198-005-1897-1. Epub 2005 Aug 9.
6
The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-alpha and anabolic bone parameters.辛伐他汀对绝经后女性血清细胞因子水平及骨代谢的影响:肿瘤坏死因子-α与骨合成代谢参数之间呈负相关。
J Bone Miner Metab. 2004;22(4):365-71. doi: 10.1007/s00774-004-0496-0.
7
Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂治疗对糖尿病患者血清辅酶Q10的影响。
Arzneimittelforschung. 1999 Apr;49(4):324-9. doi: 10.1055/s-0031-1300422.
8
Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.辛伐他汀对血液透析患者高敏C反应蛋白和血清白蛋白的影响。
Am J Kidney Dis. 2002 Jun;39(6):1213-7. doi: 10.1053/ajkd.2002.33393.
9
Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.他汀类药物与非他汀类降脂治疗对高血脂患者骨形成和骨密度生物标志物的影响。
Bone. 2010 Apr;46(4):1011-5. doi: 10.1016/j.bone.2009.12.023. Epub 2010 Jan 4.
10
Statins decrease bone turnover in postmenopausal women: a cross-sectional study.他汀类药物可降低绝经后女性的骨转换:一项横断面研究。
Eur J Clin Invest. 2002 Aug;32(8):581-9. doi: 10.1046/j.1365-2362.2002.01024.x.

引用本文的文献

1
Multiple drilling combined with simvastatin versus multiple drilling alone for the treatment of avascular osteonecrosis of the femoral head: 3-year follow-up study.多次钻孔联合辛伐他汀与单纯多次钻孔治疗股骨头缺血性坏死的3年随访研究。
BMC Musculoskelet Disord. 2016 Aug 15;17(1):344. doi: 10.1186/s12891-016-1199-0.
2
New Clues that May Link Osteoporosis to the Circulating Lipid Profile.新线索或可将骨质疏松症与循环脂质谱联系起来。
Bone Res. 2013 Sep 25;1(3):260-6. doi: 10.4248/BR201303004. eCollection 2013 Sep.
3
Therapeutic perspectives.
治疗前景。
Clin Cases Miner Bone Metab. 2008 Jan;5(1):45-8.
4
The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review.羟甲基戊二酰辅酶 A 还原酶抑制剂在风湿性疾病中的多效作用:全面综述。
Rheumatol Int. 2012 Feb;32(2):287-94. doi: 10.1007/s00296-011-2008-6. Epub 2011 Jul 31.
5
Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay.瘦素通过下丘脑中继增加成骨细胞特异性骨钙素的释放。
Peptides. 2009 May;30(5):967-73. doi: 10.1016/j.peptides.2009.01.020. Epub 2009 Feb 7.
6
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.骨转换的生化标志物:在绝经后骨质疏松症的调查与管理中的潜在应用
Osteoporos Int. 2008 Dec;19(12):1683-704. doi: 10.1007/s00198-008-0660-9. Epub 2008 Jul 16.
7
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?动脉粥样硬化与骨质疏松症:年龄依赖性退行性病变还是相关联的疾病实体?
Osteoporos Int. 2009 Feb;20(2):197-207. doi: 10.1007/s00198-008-0648-5. Epub 2008 May 29.
8
Locally applied simvastatin promotes fracture healing in ovariectomized rat.局部应用辛伐他汀可促进去卵巢大鼠的骨折愈合。
Osteoporos Int. 2007 Dec;18(12):1641-50. doi: 10.1007/s00198-007-0412-2. Epub 2007 Jul 11.
9
The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.辛伐他汀对人骨髓基质细胞增殖和分化的影响。
J Korean Med Sci. 2005 Jun;20(3):438-44. doi: 10.3346/jkms.2005.20.3.438.
10
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.世界的“他汀奇迹”:万灵药还是即将破灭的泡沫。
J Negat Results Biomed. 2005 Mar 23;4:3. doi: 10.1186/1477-5751-4-3.